What is Leitekang (Suzhou) Biopharmaceuticals worth?
$76.8Mlast known valuation
Free account
See the evidence behind this price
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Leitekang (Suzhou) Biopharmaceuticals
- ·The full record, as it builds
Create free account
No card required
Funding history
No rounds on record
No funding rounds for Leitekang (Suzhou) Biopharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
How Leitekang (Suzhou) Biopharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Leitekang (Suzhou) Biopharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Leitekang (Suzhou) Biopharmaceuticals worth?
- Leitekang (Suzhou) Biopharmaceuticals's last known valuation is $76.8M.
- How much has Leitekang (Suzhou) Biopharmaceuticals raised?
- Leitekang (Suzhou) Biopharmaceuticals has raised $4.3M in total funding across its recorded rounds.